These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9663359

  • 41. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 42. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
    Clark DJ, Lipworth BJ.
    Thorax; 1997 Jan 29; 52(1):55-8. PubMed ID: 9039246
    [Abstract] [Full Text] [Related]

  • 43. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
    Lee YS, Lin HC, Huang CD, Lee KY, Liu CY, Yu CT, Wang CH, Kuo HP.
    Chang Gung Med J; 2011 Jan 29; 34(4):382-94. PubMed ID: 21880193
    [Abstract] [Full Text] [Related]

  • 44. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
    Wasserman SI, Gross GN, Schoenwetter WF, Munk ZM, Kral KM, Schaberg A, Kellerman DJ.
    J Asthma; 1996 Jan 29; 33(4):265-74. PubMed ID: 8707781
    [Abstract] [Full Text] [Related]

  • 45. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
    Am J Respir Crit Care Med; 1999 Jul 29; 160(1):157-61. PubMed ID: 10390394
    [Abstract] [Full Text] [Related]

  • 46. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
    Harrison TW, Wisniewski A, Honour J, Tattersfield AE.
    Thorax; 2001 Mar 29; 56(3):186-91. PubMed ID: 11182010
    [Abstract] [Full Text] [Related]

  • 47. A placebo controlled trial of fluticasone propionate in asthmatic children.
    MacKenzie CA, Weinberg EG, Tabachnik E, Taylor M, Havnen J, Crescenzi K.
    Eur J Pediatr; 1993 Oct 29; 152(10):856-60. PubMed ID: 8223792
    [Abstract] [Full Text] [Related]

  • 48. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
    Lumry WR, Conway MM, LaForce CF, Pearlman DS, Scott CA, Herje NE, Wu WW, Crim C.
    Ann Allergy Asthma Immunol; 2006 Jan 29; 96(1):51-9. PubMed ID: 16440533
    [Abstract] [Full Text] [Related]

  • 49. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul 29; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 50. Fluticasone propionate in asthma: a long term dose comparison study.
    Verona E, Petrov D, Cserhati E, Hofman J, Geppe N, Medley H, Hughes S.
    Arch Dis Child; 2003 Jun 29; 88(6):503-9. PubMed ID: 12765916
    [Abstract] [Full Text] [Related]

  • 51. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients.
    Pieters WR, Stallaert RA, Prins J, Greefhorst AP, Bosman HG, van Uffelen R, Schreurs AJ, van Helmond JL, Janssen PG.
    J Asthma; 1998 Jun 29; 35(4):337-45. PubMed ID: 9669827
    [Abstract] [Full Text] [Related]

  • 52. Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma.
    Brabson JH, Clifford D, Kerwin E, Raphael G, Pepsin PJ, Edwards LD, Srebro S, Rickard K.
    Am J Med; 2002 Jul 29; 113(1):15-21. PubMed ID: 12106618
    [Abstract] [Full Text] [Related]

  • 53. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma.
    Boulet LP, Cowie RL, Negro RD, Brett W, Gold M, Marques A, Thorburn WS, Stepner NM, Robson R.
    Can Respir J; 2000 Jul 29; 7(3):239-47. PubMed ID: 10903487
    [Abstract] [Full Text] [Related]

  • 54. Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma.
    Hofstra WB, Neijens HJ, Duiverman EJ, Kouwenberg JM, Mulder PG, Kuethe MC, Sterk PJ.
    Pediatr Pulmonol; 2000 Jun 29; 29(6):415-23. PubMed ID: 10821721
    [Abstract] [Full Text] [Related]

  • 55. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group.
    Ayres JG, Bateman ED, Lundbäck B, Harris TA.
    Eur Respir J; 1995 Apr 29; 8(4):579-86. PubMed ID: 7664857
    [Abstract] [Full Text] [Related]

  • 56. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma.
    Price JF, Russell G, Hindmarsh PC, Weller P, Heaf DP, Williams J.
    Pediatr Pulmonol; 1997 Sep 29; 24(3):178-86. PubMed ID: 9330414
    [Abstract] [Full Text] [Related]

  • 57. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.
    Noonan M, Chervinsky P, Busse WW, Weisberg SC, Pinnas J, de Boisblanc BP, Boltansky H, Pearlman D, Repsher L, Kellerman D.
    Am J Respir Crit Care Med; 1995 Nov 29; 152(5 Pt 1):1467-73. PubMed ID: 7582278
    [Abstract] [Full Text] [Related]

  • 58. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
    Baraniuk J, Murray JJ, Nathan RA, Berger WE, Johnson M, Edwards LD, Srebro S, Rickard KA.
    Chest; 1999 Sep 29; 116(3):625-32. PubMed ID: 10492263
    [Abstract] [Full Text] [Related]

  • 59. Safety, efficacy, and dose response of fluticasone propionate delivered via the novel MDPI in patients with severe asthma: A randomized, controlled, dose-ranging study.
    Bernstein DI, Gillespie M, Song S, Steinfeld J.
    J Asthma; 2017 Aug 29; 54(6):559-569. PubMed ID: 27937064
    [Abstract] [Full Text] [Related]

  • 60. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
    Perruchoud AP, Lundback B, Yigla M, Sykes AP.
    Respir Med; 2000 Jun 29; 94 Suppl B():S35-41. PubMed ID: 10919684
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.